Targeted Oncology4d
FDA Grants Orphan Drug Designation to PEP-010 in Pancreatic Cancer
The FDA granted an orphan drug designation to PEP-010 for the treatment of patients with metastatic pancreatic cancer.
Hosted on MSN1mon
Scientists uncover key mechanism linking microtubules and chemotherapy, enhancing cancer drug efficacy
This explains why many chemotherapeutic drugs ... linked to the efficacy of paclitaxel, which is among the most successful chemotherapeutic agents under the class of taxanes for treating ovarian ...
PEP-Therapy receives FDA Orphan Drug Designation for PEP-010 for treatment of Pancreatic Cancer
Therapy receives FDA Orphan Drug Designation for PEP-010for treatment of Pancreatic CancerParis (France), March 17, 2025 – ...
Morningstar8d
PEP-Therapy receives FDA Orphan Drug Designation for PEP-010 for treatment of Pancreatic Cancer
PEP-010, PEP-Therapy’s first-in-class bifunctional ... with chemotherapy (paclitaxel or gemcitabine), in particular in patients with pancreatic cancer. “Obtaining Orphan Drug Designation ...